Fenway Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Newdelhi, Delhi, India, established in 2021.
2021 Newdelhi, Delhi, India Active
Last Updated:
Access Report
About Fenway Pharmaceuticals Private Limited

Fenway Pharmaceuticals Private Limited, a active private limited company, was established on 09 June 2021 in Newdelhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239DL2021PTC382105. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.40 Cr and a paid-up capital of ₹7.85 M.

Employing 36 professional, Its leadership includes Akshay Navaladi (Director), Ramesh Navaladi (Director). It holds ₹5.00 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2022, with the balance sheet filed on 31 March 2022. It is based at 313 Sfs Hauz Khas, Newdelhi, Delhi, 110016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2021PTC382105

  • Registration Number

    382105

  • Incorporation Date

    09 June 2021

  • Authorized Capital

    ₹3.40 Cr

  • Paid-Up Capital

    ₹7.85 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.40 Cr
  • Paid Up Capital ₹ 7.85 M
  • Company Age 4 Year, 8 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 5.00 Cr
Company report

Fenway Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fenway Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Fenway Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Akshay Navaladi Director 09 Jun 2021 Current
Ramesh Navaladi Director 09 Jun 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fenway Pharmaceuticals.

Fenway Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Fenway Pharmaceuticals revenue growth over time
Fenway Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fenway Pharmaceuticals?

In 2022, Fenway Pharmaceuticals had a public holding of 36.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 5.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Jan 2022 Others ₹5.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Fenway Pharmaceuticals?

Fenway Pharmaceuticals has a workforce of 36 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fenway Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fenway Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fenway Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Fenway Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2022 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Fenway Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was documented.

  • Charges

    A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100533951 was registered on 27 Jan 2022. was recorded as a recent event.

  • Director Appointment

    The activity Akshay Navaladi was appointed as a Director was appointed as a Director on 09 Jun 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Director Appointment

    Progress on Ramesh Navaladi was appointed as a Director was appointed as a Director on 09 Jun 2021 & has been associated with this company since 4 years 8 months . was documented.

  • Company Incorporation

    Fenway Pharmaceuticals Private Limited was registered on 09 Jun 2021 with Roc Delhi & aged 4 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fenway Pharmaceuticals Private Limited?

The CIN of Fenway Pharmaceuticals Private Limited is U24239DL2021PTC382105.

Where is Fenway Pharmaceuticals Private Limited headquartered?

Fenway Pharmaceuticals Private Limited is headquartered at 313 Sfs Hauz Khas, Newdelhi, Delhi, 110016.

When was Fenway Pharmaceuticals Private Limited incorporated?

Fenway Pharmaceuticals Private Limited was incorporated on 09 June 2021.

Who are the current directors of Fenway Pharmaceuticals Private Limited?

The current directors of Fenway Pharmaceuticals Private Limited are

What is the primary industry of Fenway Pharmaceuticals Private Limited?

The primary industry of Fenway Pharmaceuticals Private Limited is Trade.

Is Fenway Pharmaceuticals Private Limited a listed company?

Fenway Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Fenway Pharmaceuticals Private Limited?

The authorized capital of Fenway Pharmaceuticals Private Limited is ₹3.40 Cr, and the paid-up capital is ₹7.85 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available